mosaic-mcp
Related Servers
Alternatives to mosaic-mcp
No user-submitted related servers found.
Related Servers
- FlicenseNot gradedqualityDmaintenanceAn advanced integrated MCP server platform that combines 600+ tools and multiple biomedical databases to enable comprehensive information retrieval across molecules, proteins, genes, and diseases for accelerating therapeutic research.38-
- FlicenseAqualityBmaintenanceBiological and medical data search MCP server.42-
- FlicenseBqualityDmaintenanceA comprehensive Model Context Protocol (MCP) server providing advanced access to the ChEMBL chemical database.2789-
- AlicenseNot gradedqualityCmaintenanceUnified MCP server providing AI-agent-ready access to AlphaFold, PubMed, ChEMBL, Ensembl, and 37+ scientific databases.MIT
- AlicenseNot gradedqualityDmaintenanceMCP server for clinical and pharmaceutical data, enabling search of ClinicalTrials.gov, PubMed, FDA, and ICH guidelines without API keys.23 npmMIT
- AlicenseNot gradedqualityCmaintenanceMCP server for biological protein design, folding, and affinity prediction using Refua tools, with optional support for ADMET, clinical simulation, preclinical planning, wet-lab automation, and more.MIT
TDQS
Scored across 44 tools
Each tool has a clearly distinct purpose, targeting specific aspects of drug discovery like target assessment, compound analysis, competitive landscape, and clinical trials. The descriptions are detailed enough to avoid confusion, even for similar-sounding tools.
All tools follow the 'mosaic_<verb>_<noun>' or 'mosaic_<noun>_<verb>' pattern in snake_case, with verbs like 'get', 'compare', 'find', 'list', and 'assess'. The naming is predictable and uniform, aiding tool selection.
With 44 tools, the server covers a broad domain thoroughly. While the count is high, each tool serves a specific function without redundancy, and the scope justifies the number. A slight reduction could improve manageability, but it's still well-scoped.
The tool set comprehensively covers drug discovery workflows: target discovery, druggability assessment, compound profiling, competitive intelligence, clinical trials, and more. Gaps are acknowledged and minimal, making the surface complete for its stated purpose.